Terconazol

Terconazole Struktur
67915-31-5
CAS-Nr.
67915-31-5
Bezeichnung:
Terconazol
Englisch Name:
Terconazole
Synonyma:
Terazol 3;R42470;Fungistat;Terazol 7;TERCONAZOLE;Terconagole;Triaconazole;Gyno-Terazol;Terconazole CRS;Terconazole (200 mg)
CBNumber:
CB9309432
Summenformel:
C26H31Cl2N5O3
Molgewicht:
532.46
MOL-Datei:
67915-31-5.mol

Terconazol Eigenschaften

Schmelzpunkt:
126.3°C
Siedepunkt:
681.8±65.0 °C(Predicted)
Dichte
1.35±0.1 g/cm3(Predicted)
storage temp. 
Inert atmosphere,Room Temperature
Löslichkeit
DMSO: soluble1mg/mL
Aggregatzustand
powder
pka
8.33±0.10(Predicted)
Farbe
white
CAS Datenbank
67915-31-5(CAS DataBase Reference)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xi
R-Sätze: 36/37/38-53
S-Sätze: 26
WGK Germany  3
RTECS-Nr. TL3564600
HS Code  2934990002
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
H413 Kann für Wasserorganismen schädlich sein, mit langfristiger Wirkung. Langfristig (chronisch) gewässergefährdend Kategorie 4
Sicherheit
P261 Einatmen von Staub vermeiden.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

Terconazol Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Terconazole is an antifungal agent somewhat more potent than clotrimazole and useful in the topical treatment of vaginal dermatophytosis and candidiasis.

Chemische Eigenschaften

White or almost white powder.

Verwenden

Terconazole belongs to a new chemical class of antifungal agents, the triazoles. Terconazole has a far greater selectively for yeast cytochrome P-450 than for mammalian microsomal cytochrome P-450 and is used as topical treatment of mycotic vaginitis. Terconazole may also be used in vitro as a potent antifungal agent to prevent the morphogenetic transformation of yeast into (pseudo-)mycelium form of Candida albicans.

Indications

Terconazole (Terazol) is a fungicidal triazole topical preparation effective against many Candida strains. It is used as either a 3-day or a 7-day course (Terazol 7—0.4% cream for 7 days or Terazol 3—0.8% cream for 3 days).

Weltgesundheitsorganisation (WHO)

Terconazole, an antifungal agent, was introduced into medicine in 1980. It is indicated for the treatment of vaginal candidiasis. It is not yet clear whether the adverse effects associated with high dose formulations are due to terconazole itself, to an excipient in the preparation or to fungal constituent.

Mechanism of action

Terconazole is effective for fungistatic action for many strains of Candida and dermatophytes. The exact mechanism of its action is unknown, although it inhibits the action of the enzyme lanosterol 1-demethylase of cytochrome P-450 of sensitive fungi (similar to other azols described above), causing a reduction in the amount of ergosterin, which is necessary for the organisms to construct membranes and to retain the appropriate permeability. It is only used externally for treating vulvovaginal candidoses. Synonyms of this drug are terazol, tercospor, and others.

Clinical Use

cis-1-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy]phenyl]-4-(1methylethyl)piperazine (Terazol), or terconazole, is a triazolederivative that is used exclusively for the control ofvulvovaginal moniliasis caused by C. albicans and otherCandida species. It is available in creams containing 0.4%and 0.8% of the free base intended for 7-day and 3-day treatmentperiods, respectively. Suppositories containing 80 mgof the free base are also available.

Terconazol Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Terconazol Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 158)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21695 55
Nanjing ChemLin Chemical Industry Co., Ltd.
025-83697070
product@chemlin.com.cn CHINA 3012 60
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
TopScience Biochemical
00852-68527855
info@itopbiochem.com China Hong Kong 902 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 47465 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-81148696 +8615536356810
1047@dideu.com China 3679 58
Fuxin Pharmaceutical
+86-021-021-50872116 +8613122107989
contact@fuxinpharm.com China 10297 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58

67915-31-5(Terconazol)Verwandte Suche:


  • TERCONAZOLE
  • 1-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-yl-piperazine
  • Piperazine,1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylMethyl)-1,3-dioxolan-4-yl]Methoxy]phenyl]-4-(1-Methylethyl)-,rel-
  • (+-)-1-{4-[cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethoxy]phenyl}-4-isopropylpiperazine
  • Fungistat
  • Piperazine, 1-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-, cis
  • Terconazole (200 mg)
  • Terconagole
  • TERCONAZOLE EPT(CRM STANDARD)
  • TERCONAZOLE USP(CRM STANDARD)
  • Triaconazole
  • R42470
  • Terconazole CRS
  • Gyno-Terazol
  • Terazol 7
  • 1-[4-[[(2RS,4SR)-2-(2,4-Dichlorophenyl)-2-[(1H-1,2,4triazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1methylethyl)piperazine
  • Terconazole USP/EP/BP
  • TerconazoleQ: What is Terconazole Q: What is the CAS Number of Terconazole Q: What is the storage condition of Terconazole
  • Terconazole (1643703)
  • Terazol 3
  • 1-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-rel-piperazine
  • 67915-31-5
  • C26H31Cl2N5O3
Copyright 2019 © ChemicalBook. All rights reserved